Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.
1. STOCK NEWS:
- Western Digital (WDC) announced a review of strategic alternatives, including the potential to split up its Flash and HDD units [more]
- An FDA panel voted to recommend emergency use authorization for Novavax's (NVAX) COVID-19 vaccine [more]
- Moderna (MRNA) reported that its COVID booster candidate showed superior antibody response against the omicron variant [more]
- Campbell Soup (CPB) reported upbeat Q3 results and raised its FY22 revenue guidance [more]
- Spirit Airlines (SAVE) postponed its special stockholder meeting relating to the proposed deal with Frontier Group (ULCC), a move JetBlue (JBLU) said it "welcomes" [more]
2. WALL STREET CALLS:
- Morgan Stanley downgrades Altria (MO) to Underweight on competition concerns [more]
- Target (TGT) downgraded to Neutral from Buy at BofA [more]
- Canopy Growth (CGC) downgraded to Underperform from Market Perform at BMO Capital [more]
- Wedbush starts Affirm (AFRM) at Underperform with $15 price target [more]
- Hanesbrands (HBI) and Kontoor Brands (KTB) downgraded to Equal Weight at Barclays [more]
3. AROUND THE WEB:
- Twitter (TWTR) will comply with Musk's demands for bot data, WaPo reports [more]
- Roku (ROKU) staff are "buzzing" about the possibility of being bought by Netflix (NFLX), Insider says [more]
- TSMC (TSM) expects revenue to be up 30% this year, Bloomberg reports [more]
- State Street (STT) tells Bloomberg not responding to Swiss blog claim bank planning bid for Credit Suisse (CS) [more]
- Eni (E), Exxon (XOM), Total (TTE), Shell (SHEL), and ConocoPhillips (COP) were selected by Qatar to join a nearly $30B LNG expansion project, Reuters reports [more]
4. MOVERS:
- Rigel Pharmaceuticals (RIGL) plunges after announcing the fostamatinib FORWARD Phase 3 results in warm autoimmune hemolytic anemia missed its primary endpoint [more]
- Allogene Therapeutics (ALLO) gains after the FDA granted RMAT designation for ALLO-501A [more]
- Zendesk (ZEN) lower after CNBC said a buyout of the company by private equity suitors is looking "less likely" [more]
- Lovesac (LOVE) declines after announcing quarterly results [more]
- Intel (INTC) slides after Citi analyst Christopher Danely said he now expects the company to negatively pre-announce or miss Q2 guidance after Intel's CFO made cautiuos comments yesterday [more]
5. EARNINGS/GUIDANCE:
- Bausch + Lomb (BLCO) reported Q1 adjusted EPS below the same period of last year [more]
- Scotts Miracle-Gro (SMG) cut its FY22 earnings guidance [more]
- Smartsheet (SMAR) provided a "beat and raise" report for Q1 [more]
- Kingsoft Cloud (KC) reported upbeat Q1 revenue [more]
- Vera Bradley (VRA) reported downbeat Q1 results [more]
INDEXES:
The Dow fell 269.24, or 0.81%, to 32,910.90, the Nasdaq lost 88.96, or 0.73%, to 12,086.27, and the S&P 500 declined 44.91, or 1.08%, to 4,115.77.